SCHEMBL6967893

SCHEMBL6967893

O=C(O)C1(c2ccc(Cl)cc2)OCC(c2ccccc2)(c2ccccc2)CO1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.40
MAPK1 P28482 1/20 0.37
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
MAPT P10636 1/20 0.36
HSD11B1 P28845 5/20 0.35
ALDH1A1 P00352 1/20 0.35
AKR1C1 Q04828 1/20 0.35
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
PTGS2 P35354 1/20 0.34
TET3 O43151 1/20 0.34
KMT2A Q03164 1/20 0.34
FBXL19 Q6PCT2 1/20 0.34
CXXC5 Q7LFL8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377756 0.95 MAPK1 (0.40) CNR1MAPK1HSD11B1ALDH1A1PTGS2
SCHEMBL6981777 0.90 AKR1C1 (0.41) MAPK1L3MBTL1ALDH1A1AKR1C1KMT2A
SCHEMBL6975695 0.88 POLB (0.38) MAPK1HSD11B1ALDH1A1PTGS2KMT2A
SCHEMBL6971210 0.85 CYP1A2 (0.41) HSD11B1KMT2A
SCHEMBL6971603 0.85 CHRNA1 (0.40) MAPTHSD11B1ALDH1A1KMT2A
SCHEMBL6982594 0.84 HSD11B1 (0.39) HSD11B1AKR1C1PTGS2KMT2A
SCHEMBL6978477 0.84 LMNA (0.39) CES2CES1L3MBTL1HSD11B1AKR1C1
SCHEMBL6973280 0.84 SLC6A2 (0.37) MAPTALDH1A1PSEN1PSEN2APH1B
SCHEMBL6982483 0.83 KIF11 (0.44) CNR1MAPK1CES2CES1HSD11B1
SCHEMBL6974413 0.83 HRH1 (0.37) CNR1MAPK1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP claimed
US-6528538-B1 Reaction of 1,3-propanediol derivative with a ketone or aldehyde MERCK PATENTGESELLSCHAFT (DE) 2003-03-04 US claimed
EP-1098893-A1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GmbH (DE) 2001-05-16 EP claimed
WO-2000004011-A1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDAEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2000-01-27 WO claimed
EP-1098893-B1 CYCLIC COMPOUNDS USEFUL IN THE TREATMENT OF DYSLIPIDEMIA, ATHEROSCLEROSIS AND DIABETES, PHARMACEUTICAL COMPOSITIONS AND PREPARATION PROCESS MERCK PATENT GMBH (DE) 2003-03-26 EP disclosed